Vyndaqel 20 MG capsule UD 120S
Ended Awarded
- Contract number
- SPE2DB25FWZ26
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,847
Award facts
- Contract value 100% obligated
- $13,846.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VYNDAQEL 20 mg capsules (unit dose, 120-count packaging) valued at $13,846.97 under a firm fixed-price contract structure. The award was made on August 22, 2025, with an ultimate completion date of September 15, 2025. This non-set-aside award represents a competitively awarded delivery order, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. VYNDAQEL (tafamidis), a specialized pharmaceutical product for treating transthyretin amyloidosis, demonstrates the company's role in supplying critical specialty medications to federal healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a major pharmaceutical distributor and federal medical procurement vendor, AmerisourceBergen has demonstrated substantial capability in fulfilling federal requirements across multiple therapeutic domains through open competition.
Quick answers
Who was awarded contract SPE2DB25FWZ26?
SPE2DB25FWZ26 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FWZ26 worth?
The government has obligated $13,847 on SPE2DB25FWZ26.
Is contract SPE2DB25FWZ26 an order under another contract?
Yes. SPE2DB25FWZ26 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FWZ26 competed?
The extent of competition for SPE2DB25FWZ26 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award